Safety and Efficacy of Combigan® Ophthalmic Solution in Korea
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and
efficacy of Combigan® (brimonidine tartrate/timolol maleate) Ophthalmic Solution in patients
with Open Angle Glaucoma or Ocular hypertension with insufficient response to local beta
blockers treated as per standard of care in clinical practice.